The effect of modified ECT on serum creatine phosphokinase. II. With subcutaneous atropine.
In the previous study, the effect of modified ECT on serum CPK was investigated. In that study, atropine was administered intravenously two minutes prior to ECT being given. In this study, the more usual clinical procedure in which atropine is administered subcutaneously is investigated. In a series of nineteen patients, four had CPK elevations beyond the normal range. These findings resemble the findings of the previous study closely, and indicate again that elevations of CPK in patients receiving ECT should be interpreted with caution.
D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000097:blood*; D004565:Electroconvulsive Therapy / Q000379:methods*; D007279:Injections, Subcutaneous; D011292:Premedication; D012640:Seizures / Q000628:therapy
D001285:Atropine; D003402:Creatine Kinase